Authors: STOECKEL K HOFHEINZ W LANEURY JP DUCHENE P SHEDLOFSKY S BLOUIN RA

Citation: K. Stoeckel et al., STABILITY OF CEPHALOSPORIN PRODRUG ESTERS IN HUMAN INTESTINAL JUICE -IMPLICATIONS FOR ORAL BIOAVAILABILITY, Antimicrobial agents and chemotherapy, 42(10), 1998, pp. 2602-2606

Authors: WATSON A HOWARD G SHEDLOFSKY S BLOUIN RA

Citation: A. Watson et al., CHANGES IN CONJUGATING AND ANTIOXIDANT ENZYMES FOLLOWING ENDOTOXIN EXPOSURE, The FASEB journal, 11(9), 1997, pp. 336-336

Authors: MCCLAIN CJ SHEDLOFSKY S BARVE S HILL DB

Citation: Cj. Mcclain et al., CYTOKINES AND ALCOHOLIC LIVER-DISEASE, Alcohol health and research world, 21(4), 1997, pp. 317-320

Authors: MAO Z SHEDLOFSKY S GERMAN T WEDLUND PJ TRAGER WF

Citation: Z. Mao et al., MECHANISMS FOR HIGH-DOSE WARFARIN THERAPY, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 80-80

Authors: RAO P JACOBSEN J SNYDER J SHEDLOFSKY S KUMAR P

Citation: P. Rao et al., THE EFFECT OF PROLONGED REPERFUSION ON HEPATIC INTERLEUKIN-1, TUMOR-NECROSIS-FACTOR LEVELS AND NITRIC-OXIDE PRODUCTION, Journal of allergy and clinical immunology, 95(1), 1995, pp. 364-364